Items where authors include "Ducharme, S."

Article

Mummery, C.J. orcid.org/0000-0002-6739-0803, Börjesson-Hanson, A., Blackburn, D.J. et al. (24 more authors) (2023) Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial. Nature Medicine, 29. pp. 1437-1447. ISSN 1078-8956

Proceedings Paper

Cohen, S., Ducharme, S., Brosch, J.R. et al. (9 more authors) (2025) Multiple‐dose results from an ongoing phase 1 study of mivelsiran, an investigational RNA interference therapeutic targeting amyloid‐beta precursor protein for Alzheimer’s disease. In: Alzheimer's & Dementia. Alzheimer's Association International Conference 2025 (AAIC 2025), 27-31 Jul 2025, Toronto, Canada. Wiley .